See more : New Silkroad Culturaltainment Limited (0472.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Awakn Life Sciences Corp. (AWKN.NE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Awakn Life Sciences Corp., a leading company in the Biotechnology industry within the Healthcare sector.
- City Pulse Multiplex Limited (CPML.BO) Income Statement Analysis – Financial Results
- Taylormade Renewables Limited (TRL.BO) Income Statement Analysis – Financial Results
- Rosinbomb (ROSN) Income Statement Analysis – Financial Results
- NEXON Co., Ltd. (3659.T) Income Statement Analysis – Financial Results
- Nanavati Ventures Limited (NVENTURES.BO) Income Statement Analysis – Financial Results
Awakn Life Sciences Corp. (AWKN.NE)
About Awakn Life Sciences Corp.
Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company is headquartered in Toronto, Canada.
| Metric | 2022 | 2021 |
|---|---|---|
| Revenue | 1.50M | 236.04K |
| Cost of Revenue | 3.05M | 512.87K |
| Gross Profit | -1.55M | -276.83K |
| Gross Profit Ratio | -103.97% | -117.28% |
| Research & Development | 1.57M | 3.31M |
| General & Administrative | 4.06M | 4.40M |
| Selling & Marketing | 1.40M | 1.63M |
| SG&A | 5.46M | 6.03M |
| Other Expenses | -2.37K | 10.35K |
| Operating Expenses | 7.64M | 9.52M |
| Cost & Expenses | 10.69M | 10.03M |
| Interest Income | 0.00 | 0.00 |
| Interest Expense | 266.52K | 205.43K |
| Depreciation & Amortization | 181.41K | 181.41K |
| EBITDA | -4.94M | -9.73M |
| EBITDA Ratio | -574.49% | -4,068.10% |
| Operating Income | -9.19M | -9.78M |
| Operating Income Ratio | -614.85% | -4,144.95% |
| Total Other Income/Expenses | 306.31K | -6.86M |
| Income Before Tax | -9.65M | -16.47M |
| Income Before Tax Ratio | -645.44% | -6,978.45% |
| Income Tax Expense | -244.87K | -310.09K |
| Net Income | -9.14M | -15.95M |
| Net Income Ratio | -611.40% | -6,755.65% |
| EPS | -0.36 | -0.73 |
| EPS Diluted | -0.36 | -0.73 |
| Weighted Avg Shares Out | 25.20M | 21.96M |
| Weighted Avg Shares Out (Dil) | 25.20M | 21.96M |
Source: https://incomestatements.info
Category: Stock Reports